Important Update From Dr. Peter DiPasquale
RE: Your Contact Lenses and Our New Partnership with Lensbox™
Dear Valued Patients,
As optometrists, Dr. DiPasquale & Associates are passionate about the eye health and safety of our patients. Given the current situation we are facing with COVID-19, we want to ensure you have access to timely refills on your contact lenses, hassle-free.
As such, we are excited to announce our new partnership with lensbox.ca, Canada’s fastest-growing, online contact lens ordering platform, partnered with eye doctors across Canada.
We chose to partner with Lensbox™, because their mission aligns with ours and using this platform allows us to truly go the extra mile to ensure your prescription is validated and that your eye health is never sacrificed as a trade-off for affordable contact lenses.
HOW IT WORKS:
- To order contact lenses, go to www.lensbox.ca. and choose your contact lenses. If you are not sure about which product to choose, or your have questions about your prescription, please call us at 519-736-2406.
- You will be prompted to upload your prescription or a photo of your contact lens container, after you choose your lenses.
- Once you have uploaded the prescription, you can click on your cart, and move forward with your payment options.
- In the check-out window, you will be prompted to provide a coupon code on the right hand side of the window. To launch our new partnership, we are offering our patients a one-time coupon code [dipasquale] on your first order, which saves you 10%.
- You will not be charged for shipping in Canada. Once you finish your transaction, your contact lens order will get processed, and your contacts will be on their way to your home.
Order Refills
If you have any questions about our new partnership, your prescription, or any eyecare related enquiries, please call us at 519-736-2406.
If you have questions regarding your transaction at lensbox.ca or Lensbox™ Rewards Program, please contact admin@lensbox.ca.
Stay healthy and safe!
Dr. Peter DiPasquale
Share This Article
Choose Your Platform: Facebook Twitter Google Plus Linkedin